摘要
目的:分析长江流域6城市185家医院以苯那普利、培哚普利和福辛普利为代表的血管紧张素转换酶抑制剂(ACEI)的利用情况及发展趋势。方法:对长江流域6城市185家医院2006—2008年苯那普利、培哚普利和福辛普利的销售金额、用药频度(DDDs)、日均费用及销售金额、DDDs排序分析。结果:长江流域6城市185家医院ACEI制剂销售金额逐年小幅递增,平均增长率为2.41%。苯那普利在上海、杭州、南京、武汉的销售金额及DDDs排序均居第1位,同步性好。结论:长江流域ACEI制剂总体增长趋缓,苯那普利是长江流域地区最常使用的ACEI品种。
OBJECTIVE： To evaluate the status quo and the tendency of the utilization of benazepril, perindopril and fosinopril in 185 hospitals of 6 cities along the Yangtze Valley. METHODS： The utilization of benazepril, perindopril and fosinopril in 185 hospitals of 6 cities along the Yangtze Valley between 2006 and 2008 were analyzed statistically in respect of the consumption sum, DDC （daily average cost） , ranking of consumption sum and DDDs. RESULTS： The consumption sum of angiotensin-converting enzyme inhibitor（ACEI） witnessed a slight year-on-year increase, up 2.41% on average. In Shanghai, Hangzhou, Nanjing and Wuhan, Benazepril took the lead on the lists of consumption sum and DDDs, showing good synchronicity. CONCLUSION ： The general development of ACEI shows a slowly upward trend in the Yangtze Valley, and Benazepril is the major choice among ACEI used along Yangtze Valley.
出处
《中国医院用药评价与分析》
2010年第9期794-796,共3页
Evaluation and Analysis of Drug-use in Hospitals of China
关键词
血管紧张素转换酶抑制剂
药物利用
经济学
药学
长江流域
Angiotensin-converting enzyme inhibitor （ ACEI ）
Drug utilization
Economics
Pharmacy
Yangtze valley
